Express Pharma
Express Pharma
Browsing tag
Dr Reddy’s Laboratories
Dr Reddy’s lines up Rs 1,500 crore capex to focus on biosimilars and injectables
Read more
Dr Reddy’s announces financial results for Q2 and H1 FY23
Read more
Three pharma companies recall products in US
Read more
IQVIA and Dr Reddy’s partner for CRM solution
Read more
Dr Reddy’s Laboratories enters into licensing agreement with Slayback Pharma
Read more
Dr Reddy’s announce launch of Bortezomib for injection, 3.5 mg single-dose vial in US
Read more
Business sustainability through compliance, process excellence and process simplification
Read more
Knowledge management in pharma industry- An overview
Read more
JB Pharma acquires four paediatric brands from Dr Reddy’s Laboratories
Read more
Dr Reddy’s launch generic version of Nexavar (sorafenib) Tablets, 200 mg in US
Read more
Posts navigation
Previous
Page 1 of 18
…
Page 3 of 18
…
Page 18 of 18
Next